1Kino T, Hatanaka H, Hashimoto M, et al. FK-506, a novel immunosuppressant isolated from a Streptomyces[J].J Antibiot, 1987, 40:1249
2Peters DH, Fitton A, Plosker GL, et al.Tacrolimus,A review of its pharmacology and therapeutic potential in hepatic and renal transplantation [J].Drugs, 1993, 46 : 746-794
4Winkler M. FK506 in clinical organ transplantation[J]. Tranaplan Int, 1994,7 : 329-333
5Jorgensen KA, Koefoed-Nielsen PB, Karamperis N. Calcineurin phosphatase activity and immunosuppression. A review on the role of calcineurin phosphatase activity and the immunosuppressive effect of cyclosporin A and tacrolimus[J]. Scand J Immunol, 2003,57(2) : 93-98
6James DG. New immunosuppressant:tacrolimus[J]. Postgrad Med J,1996,72(852) : 586
7Ahsan N. Successful reversal of acute vascular rejection in a renal allograft with combined mycophenolate mofetil and tacrolimus as primary immunotherapy [J].Clin Transplantation, 1997, 11:94-98
8The US Muticenter FK506 Liver Study Group. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation[J].N Engl J Med, 1994,331:1110
9Schleibner S, Krauss M, Wagner K, et al. FK506 versus closporin in the prevention of renal allograft rejection. European pilot study: six-week results[J].Transpl Int , 1995, 8:86
10McCarey DW, Capell HA, Madhok R. Tacrolimus therapy in rheumatoid arthritis[J]. Rheumatology (Oxford), 2004, 43(8): 946-948
